Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Genentech Fully Integrated, Roche Lays Out Pipeline

Executive Summary

In Roche's first research overview since acquiring Genentech last year, management sought to assure investors that the research engine that developed breakthrough blockbuster medicines like Herceptin and Avastin is still innovating

You may also be interested in...



Merck R&D: A Jam-Packed Pipeline But Much Of It Wait-And-See

Following the acquisition of Schering-Plough, Merck has one of the most robust pipelines in the industry, but after an R&D day May 11, much of the most interesting data is still yet to be seen.

Merck R&D: A Jam-Packed Pipeline, But Much Of It Is Wait-And-See

With Schering-Plough's research now tucked snugly in with Merck's, the combined company met with analysts and investors for its widely anticipated R&D overview May 11. Even as management laid out a deep mid- to late-stage pipeline especially rich in cardiovascular products, executives provided little in the way of scientific news

Merck R&D: A Jam-Packed Pipeline, But Much Of It Is Wait-And-See

With Schering-Plough's research now tucked snugly in with Merck's, the combined company met with analysts and investors for its widely anticipated R&D overview May 11. Even as management laid out a deep mid- to late-stage pipeline especially rich in cardiovascular products, executives provided little in the way of scientific news

Related Content

Topics

UsernamePublicRestriction

Register

PS052063

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel